Strategic Overview

Hugo Biotech develops TB-EASY and TB Pro, decentralized molecular tests and targeted NGS solutions for TB diagnosis and drug resistance testing.

Innovation Portfolio

TB-EASY
Category: DIAGNOSIS Stage: Late Stage

Simplified molecular platform for MTBC detection optimized for tongue swab or sputum samples. Designed for district-level deployment with minimal training requirements.

Molecular Swab/Sputum
TB Pro
Category: DRUG RESISTANCE Stage: Late Stage

Targeted next-generation sequencing assay for comprehensive TB drug resistance profiling. Designed for central laboratory deployment with streamlined workflow vs research NGS.

tNGS Various

Key Milestones

TB-EASY decentralized molecular test
89.6% sensitivity for tongue samples
TB Pro targeted NGS for comprehensive resistance profile
Multiple disease target capability